New hope for advanced cervical cancer: drug combo trial shows promise
NCT ID NCT04982237
First seen Nov 19, 2025 · Last updated May 05, 2026 · Updated 22 times
Summary
This phase 3 trial tests whether adding the drug AK104 to standard chemotherapy (with or without bevacizumab) helps people with advanced cervical cancer live longer without their disease getting worse. About 445 women whose cancer has spread or returned and cannot be cured by surgery or radiation are taking part. The study compares the new combination to a placebo plus chemo to see if it improves survival and tumor shrinkage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Provincial Hospital
Hefei, China
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
-
The Second Affiliated Hospital,Anhui Medical University
Hefei, China
-
Women's Hospital School Of Medicine Zhejiang University
Hangzhou, China
-
Zhejiang Cancer Hospital
Hangzhou, China
Conditions
Explore the condition pages connected to this study.